Antibiotic efficacy and microbial virulence during space flight

Trends in Biotechnology

Volumn 24, Issue 3, 2006, Pages 131-136

  Klaus, David M ^a   Howard, Heather N ^a  

^a UCB 450   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; MICROORGANISMS; SPACE FLIGHT; SPACECRAFT;

INFECTIOUS DISEASE; MICROBIAL VIRULENCE; SPACE HABITATION;

ANTIBIOTICS;

ANTIBIOTIC AGENT; CATECHOLAMINE; COTRIMOXAZOLE;

ANTIBIOTIC RESISTANCE; BIOTECHNOLOGY; COSMONAUT; DRUG EFFICACY; HUMAN; IMMUNE SYSTEM; IN VITRO STUDY; INFECTION; MICROCLIMATE; MICROFLORA; MICROORGANISM DETECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPACE FLIGHT; VIRULENCE;

ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; HUMANS; OPPORTUNISTIC INFECTIONS; SPACE FLIGHT;

EID: 33644511687     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2006.01.008     Document Type: Review

References (59)

1. Institute of Medicine (2001) Executive summary. In Safe Passage Astronaut Care for Exploration Missions (Ball, J.R. and Evans, C.H., eds), pp. 1-21, National Academy Press
2. Institute of Medicine (2005) NASA's Bioastronautics Critical Path Roadmap, National Academy Press
3. A.T. Borchers Microgravity and immune responsiveness: implications for space travel Nutrition 18 2002 889 898
4. G. Sonnenfeld, and T.S. Shearer Immune function during space flight Nutrition 18 2002 899 903
5. D.M. Klaus Space microbiology: microgravity and microorganisms G. Britton The Encyclopedia of Microbiology 2002 John Wiley and Sons 2996 3004
6. N.M.E.J. Leys Space flight effects on bacterial physiology J. Biol. Regul. Homeost. Agents 18 2004 193 199
7. C.A. Nickerson Microgravity as a novel environmental signal affecting Salmonella enterica serovar Typhimurium virulence Infect. Immun. 68 2000 3147 3152
8. J.W. Wilson Low-shear modeled microgravity alters the Salmonella enterica serovar typhimurium stress response in an RpoS-independent manner Appl. Environ. Microbiol. 68 2002 5408 5416
9. s in general resistance conferred by low-shear simulated microgravity in Escherichia coli J. Bacteriol. 186 2004 8207 8212
10. Du, J. et al. (2002) Stability of pharmaceuticals during space flight. AAPS PharmSci. 4, Abstract T3153 (http://www.aapspharmaceutica.com)
11. Ilyin, V.K. (1989) Drug resistance of E. coli isolated from cosmonauts. In USSR Space Life Sciences Digest NASA Contractor Report 3922(29) (Hooke, L.R. et al., eds), pp. 67, NASA
12. Ilyin, V.K. (1990) Study of genetic characteristics and sensitivity to antibiotics of opportunistic microorganisms isolated in sealed environments. In USSR Space Life Sciences Digest NASA Contractor Report 3922(38) (Stone, L.R. and Rowe, J., eds), pp. 48, NASA
13. Meehan, R.T. et al. (1993) Infectious disease risks associated with exposure to stressful environments (SAE 932140). SAE Technical Paper Series (http://www.sae.org/servlets/productDetail?PROD_TYP=PAPER&PROD_CD=932140)
14. C.A. Nickerson Microbial responses to microgravity and other low-shear environments Microbiol. Mol. Biol. Rev. 68 2004 345 361
15. D.M. Klaus Clinostats and bioreactors Gravit. Space Biol. Bull. 14 2001 55 64
16. C.A. Nickerson Low-shear modeled microgravity: a global environmental regulatory signal affecting bacterial gene expression, physiology, and pathogenesis J. Microbiol. Methods 54 2003 1 11
17. M. Juergensmeyer Long-term exposure to spaceflight conditions affects bacterial response to antibiotics Microgravity Sci. Technol. 12 1999 41 47
18. M.A. Kacena, and P. Todd Gentamicin: effect on E. coli in space Microgravity Sci. Technol. 12 1999 135 137
19. L. Lapchine Antibiotic activity in space Drugs Exp. Clin. Res. 12 1986 933 938
20. rd European Symposium on Life Sciences Research in Space (ESA SP-271), 305-306
21. Lapchine, L. et al. (1988) The antibio experiment. In Biorack on Spacelab D1 (ESA SP-1091) (Longdon, N. and David, V., eds), pp. 45-51, ESA
22. N. Moatti Preliminary results of the 'antibio' experiment Naturwissenschaften 73 1986 413 414
23. R. Tixador Preliminary results of Cytos 2 experiment Acta Astronaut. 12 1985 131 134
24. R. Tixador Study of minimal inhibitory concentration of antibiotics on bacteria cultivated in vitro in space (Cytos 2 experiment) Aviat. Space Environ. Med. 56 1985 748 751
25. R. Tixador Behavior of bacteria and antibiotics under space conditions Aviat. Space Environ. Med. 65 1994 551 556
26. A. Graebe Physiological, pharmacokinetic and pharmacologic changes in space J. Clin. Pharmacol. 44 2004 837 853
27. Polikarpov, N.A. and Bragina, M.P. (1989) Sensitivity to antibiotics of opportunistic human indigenous microorganisms before and after isolation in an airtight environment. In USSR Space Life Sciences Digest NASA Contractor Report 3922(28) (Hooke, L.R. et al., eds), pp. 61, NASA
28. G.R. Taylor Space microbiology Annu. Rev. Microbiol. 28 1974 121 137
29. Pierson, D.L. et al. (1993) Preflight and postflight microbiological results from 25 space shuttle crews (SAE 932139). SAE Technical Paper Series (http://www.sae.org/servlets/productDetail?PROD_TYP=PAPER&PROD_CD=932139)
30. V.A. Castro Microbial characterization during the early habitation of the international space station Microb. Ecol. 47 2004 119 126
31. C.M. Ott Microbial characterization of free floating condensate aboard the Mir space station Microb. Ecol. 47 2004 133 136
32. N.D. Novikova Review of the knowledge of microbial contamination of the Russian manned spacecraft Microb. Ecol. 47 2004 127 132
33. J.W. Wilson Microarray analysis identifies Salmonella genes belonging to the low-shear modeled microgravity regulon Proc. Natl. Acad. Sci. U. S. A. 99 2002 13807 13812
34. Poudrier, J.K. (2003) Can microgravity change a bacterium's virulence? Space Research, 3, 10-11 and 20 (http://spaceresearch.nasa.gov/docs/ spaceresearch_v3n1winter2003_low.pdf )
35. Powers, B. and Carter-Snare, C. (2004) A tiny threat packs a big punch. Space Research 3, 16-17 {authors?}
36. E.R. Morey Spaceflight and bone turnover: correlation with a new rat model of weightlessness Bioscience 29 1979 168 172
37. H. Aviles Increased susceptibility to Pseudomonas aeruginosa infection under hind limb unloading conditions J. Appl. Physiol. 95 2003 73 80
38. T. Belay Effects of the hindlimb-unloading model of spaceflight conditions on resistance of mice to infection with Klebsiella pneumoniae J. Allergy Clin. Immunol. 110 2002 262 268
39. Christensen, N.J. et al. (1997) Lymphocyte norepinephrine and epinephrine as indices of long-term changes in sympathoadrenal activity in human subjects. J. Gravit. Physiol. 4, P115-116
40. H. Aviles Effects of space flight conditions on the function of the immune system and catecholamine production simulated in a rodent model of hindlimb unloading Neuroimmunomodulation 12 2005 173 181
41. H. Aviles Active hexose correlated compound enhances resistance to Klebsiella pneumoniae infection in mice in the hindlimb-unloading model of spaceflight conditions J. Appl. Physiol. 95 2003 491 496
42. V.M. Shilov Changes in the microflora of man during long-term confinement Life Sci. Space Res. 9 1971 43 49
43. E.L. Snary Antimicrobial resistance: a microbial risk assessment perspective J. Antimicrob. Chemother. 53 2004 906 917
44. M. Barlow, and B.G. Hall Experimental prediction of natural evolution of antibiotic resistance Genetics 163 2003 1237 1241
45. F. Baquero Low-level antibacterial resistance: a gateway to clinical resistance Drug Resist. Updat. 4 2001 93 105
46. M.L. Cohen Changing patterns of infectious disease Nature 406 2000 762 767
47. Y.M. Lee Targeting virulence for antimicrobial chemotherapy Curr. Opin. Pharmacol. 3 2003 513 519
48. D.I. Andersson Persistence of antibiotic resistant bacteria Curr. Opin. Microbiol. 6 2003 452 456
49. M.L. Porter, and K.A. Crandall Lost along the way: the significance of evolution in reverse Trends Ecol. Evol. 18 2003 541 547
50. S. Monroe, and R. Polk Antimicrobial use and bacterial resistance Curr. Opin. Microbiol. 3 2000 496 501
51. J.W. Wilson Mechanisms of bacterial pathogenicity Postgrad. Med. J. 78 2002 216 224
52. Institute of Medicine (1998) Workshop summary. In Antimicrobial Resistance: Issues and Options (Harrison, P.F. and Lederberg, J., eds), pp. 1-7, National Academy Press
53. K. Madaras-Kelly Optimizing antibiotic use in hospitals: the role of population-based antibiotic surveillance in limiting antibiotic resistance Pharmacotherapy 23 2003 1627 1633
54. Tolmasky, M.E. (2000) Bacterial resistance to aminoglycosides and beta-lactams: the Tn1331 transposon paradigm. Front. Biosci. 5, D20-29
55. O. Lomovskaya, and W. Watkins Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria J. Mol. Microbiol. Biotechnol. 3 2001 225 236
56. C. Ma, and G. Chang Structure of the multidrug resistance efflux transporter EmrE from Escherichia coli Proc. Natl. Acad. Sci. U. S. A. 101 2004 2852 2857
57. C.T. Barrett, and J.F. Barrett Antibacterials: are the new entries enough to deal with the emerging resistance problems? Curr. Opin. Biotechnol. 14 2003 621 626
58. F.R. Schmidt The challenge of multidrug resistance: actual strategies in the development of novel antibacterials Appl. Microbiol. Biotechnol. 63 2003 335 343
59. V.K. Ilyin Microbiological status of cosmonauts during orbital spaceflights on Salyut and Mir orbital stations Acta Astronaut. 56 2005 839 850